猪肉板块高开，大禹生物、傲农生物涨超9%，东瑞股份、得利斯、正虹科技跟涨。 ...

2025 年 12 月 1 福建傲农生物科技集团股份有限公司 2025 年第四次临时股东会会议资料 目 录 福建傲农生物科技集团股份有限公司 2025 年第四次临时股东会会议资料 证券代码：603363 证券简称：傲农生物 福建傲农生物科技集团股份有限公司 2025 年第四次临时股东会 会议资料 福建傲农生物科技集团股份有限公司 2025 年第四次临时股东会会议资料 福建傲农生物科技集团股份有限公司 2025 年第四次临时股东会会议须知 各位股东及股东代表： 为了维护广大投资者的合法权益，确保福建傲农生物科技集团股份有限公司 （以下简称"公司"）2025 年第四次临时股东会顺利召开，根据《公司法》、《公 司章程》及公司《股东会议事规则》等有关规定，制定本须知，请出席股东会的 全体人员自觉遵守。 1、本次股东会设会务组，由公司证券部负责会议的程序安排和会务工作。 2、请出席股东会的股东或股东代理人（以下统称"股东"）务必携带相关证 明材料原件（身份证、授权委托书、证券账户卡、法定代表人资格有效证明、加 盖公章的法人股东营业执照复印件等）于 2025 年 12 月 26 日下午 13:30-14:00 准时到达会 ...

Group 1: Report's Core View - In 2025, the overall commodity market showed a high - opening and low - closing trend. Agricultural products were less affected by macro - liquidity but pressured by cyclical factors. The downstream of the breeding industry chain led the decline, and pig prices hit a new low in Q3 2025. The industry focused on cost - reduction and efficiency - improvement, with no significant increase in absolute production capacity, but the production efficiency of sows improved [2]. - Looking ahead to H1 2026, it's difficult for feed costs to continue to decline. As the de - stocking of pig production capacity deepens, pig prices are expected to rise. It is recommended to buy contracts after 2607 below the breeding cost or go long on market volatility in Q2 [3]. Group 2: Industry Investment Rating - There is no information about the industry investment rating in the report. Group 3: Summary by Directory Part 1: Review of 2025 Pig Futures and Spot Prices 1. Review of Pig Futures and Spot Price Quotes - In 2025, domestic policies increased liquidity, but the economy still faced pressure. Commodity prices were polarized, and agricultural products generally fell. The downstream of the feed - breeding industry chain was under pressure due to over - capacity and weak demand [11]. 2. Summary of Characteristics of Typical Pig Cycle Bottoms in the Past - Different pig cycles had different bottom characteristics in terms of time, pig and piglet prices, sow inventory, and reasons for the bottom, such as diseases, trade issues, and policy impacts [47]. 3. Pig Futures Trading Volume and Open Interest - There is no specific content about pig futures trading volume and open interest in the given text. Part 2: Supply - Demand Fundamentals of Pigs 1. Supply Side - The industry's absolute production capacity did not increase significantly, but the average PSY of sows increased from 24 to over 26, with some leading enterprises approaching 29. The growth of sow inventory was limited [2]. 2. Demand Side - In 2025, consumer confidence was low, and food consumption was at a low level. The slaughter volume of large - scale pig slaughtering enterprises increased year - on - year, but the profit and capacity utilization rate of slaughtering enterprises were relatively low [78]. 3. Pork Supply - Demand Balance Sheet and Related Meat Production - From 2010 to 2025E, the pork supply - demand balance sheet showed changes in production, imports, supply, and demand. In 2025E, production was 5230000 tons, imports were 80000 tons, and the supply - demand difference was 168000 tons [95]. 4. Pig Breeding Profit and Cost - The average breeding cost of group enterprises decreased. The profit of pig breeding showed seasonal and annual fluctuations, with significant differences between self - breeding and self - raising and purchasing piglets for fattening [101][108][109]. 5. Seasonal Characteristics of Pig Prices - Pig prices showed certain seasonal patterns, with different monthly price changes in different years [112]. Part 3: Technical Analysis of Pig Futures and Option Strategies 1. Technical Analysis of Pig Futures - There is no specific content about the technical analysis of pig futures in the given text. 2. Pig Options - There is no specific content about pig options in the given text. Part 4: Outlook for the 2026 Pig Market - In 2026, it's difficult for feed costs to decline further. As the de - stocking of production capacity deepens, pig prices are expected to gradually recover from the bottom [3]. Appendix: Performance of Stock Prices of Related Listed Pig Companies - As of certain dates, different listed pig companies had different stock price performances and annual cumulative price change rates [124].

Core Insights - The pig industry is entering its peak season, but the market has not yet emerged from a "cold winter" with significant losses continuing despite increased sales volume [1][4] - Major listed pig companies have reported a general increase in slaughter volume, with some companies achieving their annual targets ahead of schedule, yet the average sales price has dropped nearly 30% year-on-year [1][4] Company Performance - Major listed pig companies have collectively slaughtered over 150 million pigs from January to November 2025, with companies like Wens Foodstuff and Zhengbang Technology completing their annual targets early [1][4] - In November, Muyuan Foods sold 6.602 million pigs, a year-on-year increase of 11.8%, while Wens Foodstuff reached a new high with 4.3535 million pigs sold, marking a 49.71% year-on-year increase [6][3] - Zhengbang Technology and Aonong Biological showed significant growth, with Zhengbang selling 868,300 pigs in November, up 63.04% year-on-year, and Aonong selling 160,000 pigs, up 72.21% year-on-year [3][6] Pricing Trends - Despite increased sales volume, the low pig prices have negatively impacted revenue for listed companies, with Muyuan's average sales price at 11.56 yuan/kg, down 28.73% year-on-year, and Wens' price at 11.71 yuan/kg, down 29.92% [3][6] - The price drop has led to a more significant decline in revenue for companies like Tangrenshen, which saw a 34.16% year-on-year decrease in sales revenue despite a 7.78% drop in sales volume [3][6] Market Dynamics - The long-term low performance of the pig market is attributed to an imbalance in supply and demand, with a high absolute number of breeding sows still present despite adjustments [4][7] - Experts indicate that while the pig market is expected to enter its peak consumption season, the overall price trend is likely to remain weak due to continued supply pressure from a high number of new piglets born earlier in the year [4][7]

证券代码：603363 证券简称：傲农生物 公告编号：2025-115 福建傲农生物科技集团股份有限公司 关于公司全资子公司履行担保代偿债务的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 福建傲农生物科技集团股份有限公司（以下简称"公司"）全资子公司 吉安市傲农现代农业科技有限公司（以下简称"吉安现代"）为永新县傲翔生态 农业科技有限公司（以下简称"永新傲翔"）提供连带责任保证担保，因永新傲 翔无力偿还，吉安现代已于 2025 年 12 月 10 日为其代偿欠款本金 600 万元。 截至本公告披露日，吉安现代作为担保人，对永新傲翔与永新县仓泰养 殖有限公司（以下简称"永新仓泰"）的担保责任已全部履行完毕，合计代偿金 额 1,052.06 万元，超过公司 2024 年末根据预计可能的损失金额计提的预计负债 金额 1,050.00 万元的部分将会对公司 2025 年度相关数据产生影响，具体数据以 公司经审计的财务报表数据为准。 公司将密切关注相关进展情况，及时履行信息披露义务。敬请广大投资 者理性投资，注意 ...

Group 1 - The company will hold its fourth extraordinary general meeting of shareholders on December 26, 2025, at 14:00 in its conference room located in Fujian Province, Zhangzhou City [2][5][15] - Voting will be conducted through a combination of on-site and online methods, with specific time slots for online voting on the same day [3][8] - The meeting will review several proposals, including special resolutions and those requiring separate voting for minority shareholders [7][29] Group 2 - The company reported a significant increase in pig sales in November 2025, with sales reaching 157,700 heads, a year-on-year increase of 72.21%, although a decrease of 17.08% compared to October 2025 [27] - As of the end of November 2025, the company had a total pig inventory of 699,700 heads, reflecting a year-on-year increase of 33.94% and a month-on-month increase of 7.58% [27][29] - The company is focusing on optimizing its pig farming capacity and will continue to implement cost-reduction strategies while developing advantageous production capacity [27]

Group 1 - Weidi Co., Ltd. plans to acquire control of Jiuxing Precision Technology, which is expected to constitute a major asset restructuring. The company will pay cash to acquire 51% of the equity from Jiangsu Zhiyue Tiancheng Enterprise Management Co., Ltd. and Jiuxing Precision Technology, aiming to gain at least 51% voting rights [2] - Purun Co., Ltd. intends to purchase 49% equity of high-performance storage company Noah Changtian through issuing shares, convertible bonds, and cash payments. Upon completion, Purun will hold 100% of Noah Changtian, which specializes in high-performance 2D NAND and derivative storage products [3] - ST Yishite is undergoing a significant share transfer, with Jiangjiang Industrial Group acquiring 4.34 billion shares, representing 18.66% of the total share capital, at a price of 5.61 yuan per share, totaling 2.437 billion yuan [5] Group 2 - Midea Group has completed its share repurchase plan, buying back 135 million shares, accounting for 1.76% of the total share capital, with a total expenditure of approximately 10 billion yuan [6] - Jingji Agricultural plans to repurchase shares using self-raised funds, with a total amount between 100 million and 200 million yuan, at a maximum price of 23.7 yuan per share [6] - Helen Zhe intends to repurchase shares with a total amount between 50 million and 100 million yuan, at a maximum price of 7.5 yuan per share [7] Group 3 - Shengda Resources plans to acquire 60% equity of Yichun Jinshi Mining for 500 million yuan, which will become a subsidiary after the transaction [7] - Guangju Energy is participating in the public transfer of an 8% stake in Shenzhen Mawan Power, aiming to increase its holding from 6.42% to 14.42% [8] - Zhongrong Marine plans to invest 2.58 billion yuan in Guangdong Yantian Port for a 20% stake through its wholly-owned subsidiary [15]

Group 1 - Cambridge Technology plans to invest 400 million yuan to establish a fund focused on optical devices and chips, aiming to invest in early-stage and growth-stage companies in the hard technology sector [1] - Tunnel Corporation's consortium won a bid for a highway project in Henan with a total investment of 6.49 billion yuan, using a BOT model for a 33.25-year cooperation period [2] - Hongrun Construction won a bid for a project worth 230 million yuan, which represents 3.88% of the company's projected revenue for 2024 [3] Group 2 - Tongrentang's product, Canling Baizhu Powder, received product registration approval from Health Canada, aimed at treating symptoms related to spleen and stomach weakness [4] - Hunan Baiyin announced a scheduled annual maintenance from December 9, 2025, to January 5, 2026, for equipment and facilities [5] - Changchun Gaoxin's subsidiary had two drugs included in the national medical insurance catalog for 2025 [6] Group 3 - Dongfang Securities' chairman resigned due to work relocation [7] - Xuantai Pharmaceutical's product, Sitagliptin Metformin Sustained-Release Tablets, was renewed for inclusion in the national medical insurance catalog [8] - ST Weihai was pre-selected for a smart agriculture EPC project with a bid of 652 million yuan, accounting for 26.27% of the company's projected revenue for 2024 [9] Group 4 - Guoxin Technology successfully tested an anti-quantum password financial POS chip, supporting both traditional and quantum-resistant algorithms [10] - Huaren Health's subsidiary received acceptance for a drug registration application for Lactulose Oral Solution, a common laxative [11] - Ankai Bus reported a 57.71% year-on-year increase in sales for the first 11 months of the year [12] Group 5 - Zhongyan Dadi's subsidiary won a bid for a project worth 73.86 million yuan [13] - Zhejiang Rongtai plans to invest 77 million USD in a factory in Thailand, focusing on mica paper and robot components production [14] - Optoelectronics plans to use up to 450 million yuan of idle funds for cash management [15] Group 6 - Tianyu Biological reported a 45.15% year-on-year decline in sales revenue from pig sales in November [16] - Daqin Railway's cargo transport volume increased by 1.75% year-on-year in November [17] - Yabo Co. won a bid for a heavy truck charging station project worth 3.616 million yuan [18] Group 7 - Hongri Pharmaceutical's product continues to be included in the national medical insurance catalog [19] - Jinggong Steel Structure signed a contract for steel structure installation worth approximately 470 million yuan for an overseas project [20] - Xizang Pharmaceutical's product, Xinhuasuan, continues to be included in the national medical insurance catalog [21] Group 8 - Guangdong Electric Power A announced the successful commissioning of a 1000MW unit at the Maoming Boge Power Plant [22] - Fuan Pharmaceutical's product, Palivizumab Injection, was newly included in the national medical insurance catalog [23] - Lizhu Group reported that 194 products were included in the 2025 national medical insurance catalog [24] Group 9 - Haisan Pharmaceutical's injection of Lantanol was included in the national medical insurance catalog [25] - Zhongtong Bus reported a 39.53% year-on-year increase in sales volume in November [26] - Shaanxi Coal Industry reported a 6.03% year-on-year increase in coal production in November [27] Group 10 - Haooubo's subsidiary received a medical device registration certificate for an IgG4 testing kit [28] - Yaopi Glass plans to invest 690 million yuan in new automotive glass production lines [30] - Huadian International completed the issuance of 2 billion yuan in medium-term notes [31] Group 11 - Zhongzai Zihuan's subsidiary won a bid for a green recycling project worth 205 million yuan [32] - Dabeinong reported a 25.26% year-on-year decline in sales revenue from pig sales in November [33] - Xiangjia Co. reported a 3.77% year-on-year increase in live poultry sales revenue in November [34] Group 12 - Huanxu Electronics reported a consolidated revenue of 5.198 billion yuan in November, a decrease of 3.34% year-on-year [35] - Aonong Biological reported a 72.21% year-on-year increase in pig sales volume in November [36] - Samsung Medical's subsidiary was pre-selected for a procurement project worth approximately 108 million yuan [37]

傲农生物（603363）(603363.SH)发布11月养殖业务主要经营数据，2025年11月，公司生猪销售量15.77 万头，同比增加72.21%，较2025年10月减少17.08%。11月末，公司生猪存栏69.97万头，同比增加 33.94%，较2025年10月末增加7.58%，较2024年12月末增加36.41%。 ...

智通财经APP讯，傲农生物(603363.SH)发布11月养殖业务主要经营数据，2025年11月，公司生猪销售量 15.77万头，同比增加72.21%，较2025年10月减少17.08%。11月末，公司生猪存栏69.97万头，同比增加 33.94%，较2025年10月末增加7.58%，较2024年12月末增加36.41%。 ...